Tag: EMA stability submission

Bracketing Studies for Cost-Effective Shelf Life Extensions

Bracketing studies offer a strategic pathway for pharmaceutical companies to reduce the cost and time involved in stability testing while still meeting regulatory expectations for shelf life extension. When executed correctly, these studies minimize testing burden while maintaining compliance, making them highly valuable for formulations with multiple strengths, fill volumes, or packaging configurations. In this…

Regulatory Submissions for Shelf Life Extensions, Shelf Life and Expiry

Communicating Risk-Based Justifications to Regulatory Agencies

Communicating risk-based justifications to regulatory agencies is a critical aspect of modern pharmaceutical stability testing. With guidelines like ICH Q9 and ICH Q1D encouraging science- and risk-based approaches, regulators now expect companies to provide solid rationale—not just data—for their testing strategies. Whether it’s bracketing, matrixing, or other streamlined stability designs, the clarity and robustness of…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

Evaluating Stability Profiles Under Accelerated Conditions

Evaluating Stability Profiles Under Accelerated Conditions How to Evaluate Stability Profiles in Accelerated Stability Testing Accelerated stability testing is a crucial step in determining the robustness of a pharmaceutical product under stress conditions. Proper evaluation of stability profiles helps forecast shelf life, detect formulation weaknesses, and support regulatory filings. This guide provides a step-by-step approach…

Real-Time and Accelerated Stability Studies, Stability Testing Types